Dokumendiregister | Terviseamet |
Viit | 11.1-12/24/8706-1 |
Registreeritud | 30.08.2024 |
Sünkroonitud | 02.09.2024 |
Liik | Sissetulev dokument |
Funktsioon | 11.1 Turustamise järgne järelevalve (post-marketing surveillance) |
Sari | 11.1-12 Turujärelevalvega seotud muu kirjavahetus („tahetakse infot“) - Nõustamine |
Toimik | 11.1-12/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | AS SEMETRON |
Saabumis/saatmisviis | AS SEMETRON |
Vastutaja | Maarika Ojala (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: Maret LƵhmus <[email protected]>
Sent: Wed, 28 Aug 2024 12:39:34 +0000
To: "'[email protected]'" <[email protected]>
Subject: pƤring
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Tere
Oleme saanud ettevõttelt Baxter allpool toodud küsimused. Ettevõte Baxter jaguneb, jagunemisel tekib uus ettevõte Vantive, millele läheb osa tooteid üle.
Palun võimaluse korral Teie abi nendele vastamisel.
Dear customer,
Following the feedback received from several local partners/distributors, the regional Baxter/Vantive team has decided that a follow-up communication should be sent to all distributors with the below list of questions. These questions will help us better understand all the information and documents needed by you to set-up Vantive as your new supplier in your systems and ensure business readiness on November 1st 2024.
Please reply back to this email answering below questions –
1. Have you identified any risks with using the Baxter logo on labels while all documents display the new entity?
2. Have you identified any risks associated with mentioning both Baxter and Vantive on various documents such as packing lists, invoices, and labels during the transition period?
Lugupidamisega/ Best regards
Maret Lõhmus
jurist/kvaliteedispetsialist
Tel: 6837 600
Fax: 6837 601
AS SEMETRON
Veerenni 51 / 10138 Tallinn / Eesti / Estonia
Hoiatus! See elektronkiri koos lisadega sisaldab konfidentsiaalset teavet ning selle edastamine kolmandatele isikutele
on keelatud.
Caution! This e-mail and attachments are confidential and may contain trade secrets or be otherwise protected from disclosure. Should you receive this e-mail and not be its intended recipient, please notify us immediately by reply e-mail and delete this e-mail
including attachments from your system. Also, it is not allowed to copy this e-mail or attachment or disclose the contents to any other person. Thank you!